Account
Inquiry
QSC Tirzepatide is a high-purity pharmaceutical grade peptide compound with CAS number 2023788-19-2. This white powder formulation has a molecular formula of C225H348N48O68 and molecular weight of 4813. As a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, QSC Tirzepatide shows significant potential for type 2 diabetes research applications.
The compound demonstrates superior efficacy in glucose control and weight management compared to single receptor agonists. Clinical studies indicate QSC Tirzepatide's unique mechanism of action combines the benefits of both GIP and GLP-1 pathways, potentially offering enhanced therapeutic effects for metabolic disorders.
Structurally similar to semaglutide, QSC Tirzepatide features a lysine side chain with PEG modification that enhances water solubility. This modification contributes to the compound's stability and bioavailability, making it particularly suitable for research purposes.
In clinical trials, QSC Tirzepatide has demonstrated significant weight reduction effects in overweight subjects, with dose-dependent responses observed. The compound has received regulatory designations to accelerate its development for obesity-related conditions.
Our QSC Tirzepatide is supplied as a lyophilized powder with purity exceeding 99.9%. The product is carefully packaged to ensure stability and longevity, with various packaging configurations available to meet different research requirements.
For optimal preservation, QSC Tirzepatide should be stored in a cool, dry environment protected from light. Avoid repeated freeze-thaw cycles and prolonged exposure to air to maintain product integrity.
